Pfizer Oncology Commits to 230K SF at Torrey View Campus

Breakthrough Properties, a joint venture of global developer Tishman Speyer and biotechnology investment firm Bellco Capital, has signed Pfizer Oncology to Torrey View, its life science campus nearing completion in San Diego. The 15-year, 230,000-square-foot lease encompasses two research and development buildings.

With the Pfizer commitment, Breakthrough Properties has now preleased the entirety of its 10-acre Torrey View campus in advance of the development’s full completion. Pfizer Oncology is joined by leading global medical technology company BD (Becton, Dickinson and Company) Biosciences Division, which began a phased move-in of its San Diego workforce in late 2023.

Eighty-nine percent of the three-building Torrey View campus is now secured by long-term investment grade credit tenants, with the balance leased to innovative hyper-growth biotechnology firms.

“Tishman Speyer is thrilled to expand our relationship with Pfizer,” said Breakthrough Properties co-chairman and Tishman Speyer CEO Rob Speyer. “Torrey View will provide Pfizer Oncology with best-in-class space that will enable scientific discoveries and new therapies to improve patients’ lives around the globe.”